Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Agence Regionale de Sante d'Ile de France | OTHER_GOV |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to determine whether Tele-expertise would be effective and cost-effective by reducing the number of secure transportations for inmates in need of a dermatological consultation
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Control group before telemedicine | Inmates of prisons not having telemedicine before implementation of telemedicine in prisons having telemedicine | ||
| Control group after telemedicine | Inmates of prisons not having telemedicine after implementation of telemedicine in prisons having telemedicine | ||
| Exposed group, before telemedicine | Inmates of prisons having telemedicine before implementation of telemedicine | ||
| Exposed group, after telemedicine | Inmates of prisons having telemedicine after implementation of telemedicine |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Telemedicine | Device | Inmates of prisons having telemedicine after implementation of telemedicine |
|
| Measure | Description | Time Frame |
|---|---|---|
| Proportion of a dermatological expertise among those required | 1 month after the end of the study |
| Measure | Description | Time Frame |
|---|---|---|
| Number of hospitalizations for a dermatological reason | 1 month after the end of the study | |
| Overall costs | 6 months after the end of the study | |
| Time to a dermatological expertise |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Inmates
Not provided
| Name | Affiliation | Role |
|---|---|---|
| François Moreau, MD | Versailles Hospital | Principal Investigator |
| Isabelle Durand-Zaleski, MD, PhD | DRCD URC Eco. Assistance Publique - Hôpitaux de Paris | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| UCSA Osny | Cergy-Pontoise | 95524 | France | |||
| UCSA Meaux |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 22617736 | Background | Kidholm K, Ekeland AG, Jensen LK, Rasmussen J, Pedersen CD, Bowes A, Flottorp SA, Bech M. A model for assessment of telemedicine applications: mast. Int J Technol Assess Health Care. 2012 Jan;28(1):44-51. doi: 10.1017/S0266462311000638. | |
| 30248151 | Derived | Zarca K, Charrier N, Mahe E, Guibal F, Carton B, Moreau F, Durand-Zaleski I. Tele-expertise for diagnosis of skin lesions is cost-effective in a prison setting: A retrospective cohort study of 450 patients. PLoS One. 2018 Sep 24;13(9):e0204545. doi: 10.1371/journal.pone.0204545. eCollection 2018. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D012871 | Skin Diseases |
| ID | Term |
|---|---|
| D017437 | Skin and Connective Tissue Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
| 1 month after the end of the study |
| Number of usual consultations needed after Tele-expertise | 1 month after the end of the study |
| Meaux |
| 77351 |
| France |
| UCSA Nanterre | Nanterre | 92014 | France |
| UCSA Réau | Réau | 77550 | France |
| UCSA Villepinte | Villepinte | 93420 | France |
| 26857558 | Derived | Charrier N, Zarca K, Durand-Zaleski I, Calinaud C; ARS Ile de France telemedicine group. Efficacy and cost effectiveness of telemedicine for improving access to care in the Paris region: study protocols for eight trials. BMC Health Serv Res. 2016 Feb 8;16:45. doi: 10.1186/s12913-016-1281-1. |